Ognian Donev is born on December 22, 1957. He studies in Hamburg and Vienna and completes its higher education in International Economic Relations in the Economic Institute in Sofia. In 1986 Mr. Donev completes his PhD in Economics in Berlin. Mr. Donev works in the private sector since 1990 and for 7 years he represents Metro Cash & Carry in Bulgaria managing the export of Bulgarian goods for the "Metro" chain (Parpool, Gemex). For the period 1993-1997 Mr. Donev represents large international traders of black metals in Bulgaria. PhD Ognian Donev is CEO of Sopharma since October 2000. He takes part in other management bodies as the Board of directors of Unipharm AD, Sopharma Trading AD, Doverie United Holding AD etc. He is Vice-president of the German-Bulgarian Trade-Industrial Chamber and a Chairman of the Bulgarian National Committee of the International Chamber of Commerce (ICC). Mr. Donev was awarded the "Burov Prize", the prize of the "Atanas Burov" Foundation for industrial management. He is Member of the Board of Europharm SMC (the European knowledge platform for small and medium-sized pharmaceutical companies).

Since the end of 2013 Ioana Bianchi is Market Access Head for Novartis Oncology in Romania. Ioana Bianchi graduated medicine at the University "Carol Davila" in Bucharest, where she specialized in "Public Health and health management". In 2007 she obtained a Maitrise from University of Medicine in Nantes, France. For more than 2 years Dr Bianchi worked as healthcare strategy consultant for the National Center for Hospital Expertise of France, where she provided  consultancy for public and private hospitals, as well as regional and national health authorities. Since 2011, Ioana Bianchi was personal advisor to the President of the National Health Insurance House in Romania working on projects with the World Bank and the International Monetary Fund. In 2012 Dr Bianchi worked as personal advisor to the Minister of Health in Romania and in 2013 she became Head of the HTA Unit in the MoH.

Mr. Deyan Denev is heading the Association of Research-based Pharmaceutical Manufacturers in Bulgaria since October 2003. He has a legal education from Sofia University and is an expert in pharmaceutical legislation and pharmaceutical policy. As Director of the association he is leading the advocacy activities of R&D pharmaceutical industry in Bulgaria on key issues regarding pharmaceutical policy, regulatory environment, intellectual property, pharmaceutical market development. He is a member of the Supervisory Board of the National Health Insurance Fund on behalf of the Confederation of Employers and Industrialists in Bulgaria since January 2014.
Between 2008 and 2013 he was a representative of the pharmaceutical industry in the Transparency Commission, which is an appeal body for all piecing and reimbursement decisions in Bulgaria. He is a member of the National HIV/AIDS Council at the Bulgarian Government and a member of the CEE Task Force of EFPIA (European Federation of Pharmaceutical Industries and Associations).

Dávid Dankó is founder and managing partner of Ideas & Solutions, an advisory firm which provides strategic consultancy to pharma and medical device companies, focusing on middle-income markets. He is also research leader at the Corvinus University of Budapest, where he lectures pharmaceutical and medical device reimbursement, health care management and health care financing. Dávid Dankó received his MSc degree in Economics at Corvinus in 2003, and his PhD degree in 2012 with a thesis on long-term resource management in the pharma industry. Dávid has 10 years of experience in health care management, gradually focusing on the economics of pharmaceuticals and medical devices. Between 2003 and 2008, he worked as a consultant specialized in health care and organization development. From 2008 to 2010, he was deputy head of the Department of Reimbursement at the Hungarian National Health Insurance Fund, where he was responsible for pharmaceutical and medical device reimbursement strategy, international cooperation as well as research and analysis. For several years, Dávid Dankó has been a lecturer at Université Claude Bernard Lyon-1 (EMAUD), Semmelweis University of Budapest, Debrecen University, Eötvös Loránd University and the former Vienna School of Clinical Research. He is a regular speaker at workshops and conferences on pharmaceutical and medical device reimbursement. He organizes and moderates payer communication and negotiation trainings for pharmaceutical and medical device companies, and co-edited a university textbook titled ‘Pharmaceutical reimbursement’ published in 2013.
Current focuses:
•     Pragmatic drug assessment systems for middle-income countries
•     Transparency of pharmaceutical decision-making processes
•     Reimbursement frameworks for biosimilar and critical dosage drugs
•     Payer negotiation and communication trainings

Agnès Couffinhal is a Senior economist at the World Bank which she joined in 2005. Prior to this, she worked for the World Health Organization and as a senior research fellow at the institute for Research and Information in Health Economics (IRDES) in France. She is a health systems and health financing expert who has predominantly worked in the greater Europe region.

Dr. Daniela Daritkova is Memeber of Parliament in the 42nd National Assembly. Born in Plovdiv. She graduated in medicine from St. Petersburg Pediatric Medical Institute.
Dr. Daritkova is a regional leader of GERB WOMEN - Smolyan. Dr. Daniela Daritkova is major candidate of GERB – Smolyan at the 2009 parliamentary elections.